Antibodies Directed Against P19 Subunit Of Human Il-23 - Use For The Preparation Of Therapeutic Molecules

Patent No. EP2583979 (titled "Antibodies Directed Against P19 Subunit Of Human Il-23 - Use For The Preparation Of Therapeutic Molecules") was filed by Effimune on Oct 19, 2011. The application was issued on Dec 16, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JANSSEN BIOTECHSep 16, 2016GOODFELLOW

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2583979

EFFIMUNE
Application Number
EP11306352A
Filing Date
Oct 19, 2011
Status
Revoked
Feb 23, 2018
Publication Date
Dec 16, 2015